The Centers for Disease Control and Prevention has launched a national surveillance system to monitor adverse events in patients who receive blood transfusions.

The Hemovigilance Module is a new component of CDC's National Healthcare Safety Network that enables the collection, tracking and analysis of data about healthcare-associated infections. CDC developed the Hemovigilance Module with AABB, formerly the American Association of Blood Banks, in Bethesda, Md.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access